Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

Share Price is delayed by 15 minutes
Get Live Data
133.80    1.20 (0.90%)
Bid:
133.20
Ask:
134.00
Spread: 0.80 (0.601%)
Market Cap: £274.99m
FORT Live PriceLast checked at - London Stock Exchange

Intraday Forterra Share Chart

Directorate Changes

25 Apr 2017 13:33

RNS Number : 2780D
Forterra plc
25 April 2017
 

25 April 2017

 

Forterra plc

Directorate Changes

Forterra plc is pleased to announce that Martin Sutherland will join the Board as an Independent Non-Executive Director with effect from the close of the AGM on 23 May 2017. Martin Sutherland is the Chief Executive Officer of De La Rue plc. Prior to joining De La Rue in 2014, Martin held senior management roles at BAE Systems plc and Detica plc.

In addition, following the announcement that an affiliate of Lone Star Funds has sold all of its remaining holding in the Company, under the terms of the Relationship Agreement between the Company and such affiliate of Lone Star, Bradley Boggess and Richard "Chip" Cammerer Jr have both resigned as Directors of the Company with immediate effect. The Relationship Agreement has now also terminated.

Following the above resignations, resolutions 10 and 11 seeking the re-election of both Brad and Chip which were to be voted upon at the AGM will now be withdrawn.

There are no other details to disclose under Listing Rule 9.6.13.

The search for a further Independent Non-Executive Director is underway and an announcement will be made when appropriate.

Paul Lester CBE, Chairman of Forterra commented "I am delighted that Martin Sutherland has agreed to join the Board of Forterra at a key stage in the Company's development. Martin has gained extensive board level experience over many years and he will be a valuable addition to the Board. I would also like to express our thanks to both Brad and Chip as they leave the Board. Their contribution in our first year as a listed company is greatly appreciated."

 

Enquiries

FTI Consulting:

+44 (0) 20 3727 1340

Richard Mountain/Nick Hasell

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUVOURBRASUAR
Date   Source Headline
28th Jan 20269:21 amRNSHolding(s) in Company
26th Jan 20264:07 pmRNSHolding(s) in Company
22nd Jan 20267:00 amRNSFull Year 2025 Trading Update
20th Jan 20267:00 amRNSEmployee Benefit Trust Share Purchase
7th Jan 20269:39 amRNSEmployee Benefit Trust Share Purchase
2nd Dec 20259:22 amRNSEmployee Benefit Trust Share Purchase
24th Nov 20259:03 amRNSHolding(s) in Company
20th Nov 20259:13 amRNSHolding(s) in Company
18th Nov 20255:03 pmRNSEmployee Benefit Trust Share Purchase
11th Nov 20257:00 amRNSTrading Update
4th Nov 20254:34 pmRNSEmployee Benefit Trust Share Purchase
24th Oct 20251:36 pmRNSHolding(s) in Company
23rd Oct 20251:21 pmRNSDirector/PDMR Shareholding
17th Oct 20259:58 amRNSEmployee Benefit Trust Share Purchase
14th Oct 20259:06 amRNSHolding(s) in Company
13th Oct 202510:15 amRNSEmployee Benefit Trust Share Purchase
2nd Oct 20252:54 pmRNSGrant of Options under 2025 SAYE Scheme
11th Aug 20251:15 pmRNSHolding(s) in Company
29th Jul 20257:38 amRNS-RProgressive publishes new research
29th Jul 20257:00 amRNSSix months ended 30 June 2025
23rd Jul 202510:05 amRNSHolding(s) in Company
19th Jun 20257:05 amRNSDirector Declaration
20th May 20251:47 pmRNSAnnual General Meeting 2025 Results
20th May 20257:43 amRNS-RProgressive publishes new research
20th May 20257:00 amRNSAGM Trading Update
13th May 202510:36 amRNSHolding(s) in Company
11th Apr 20259:18 amRNSDirector / PCA Shareholdings
2nd Apr 20252:22 pmRNSDirector/PDMR Shareholding
26th Mar 20255:53 pmRNSAnnual Report & Accounts 2024 & Notice of AGM 2025
25th Mar 20251:47 pmRNSDirector/PDMR Shareholding
20th Mar 20252:44 pmRNSHolding(s) in Company
20th Mar 20257:00 amRNSGrant under Performance Share Plan
20th Mar 20257:00 amRNSGrant under Deferred Annual Bonus Plan
18th Mar 20252:23 pmRNSHolding(s) in Company
12th Mar 20258:14 amRNS-RProgressive publishes new research
12th Mar 20257:00 amRNSFull Year Results
6th Mar 20257:00 amRNSAppointment of Independent Non-Executive Director
27th Feb 20253:35 pmRNSHolding(s) in Company
26th Feb 20252:50 pmRNSHolding(s) in Company
4th Feb 20257:00 amRNSDirectorate Change
23rd Jan 20257:00 amRNSFull Year 2024 Trading Update
6th Jan 20259:23 amRNSHolding(s) in Company
2nd Jan 202511:38 amRNSDirector/PDMR Shareholding
11th Nov 20247:00 amRNSTrading update to the end of the October
4th Nov 202410:24 amRNSHolding(s) in Company
30th Oct 20244:54 pmRNSHolding(s) in Company
28th Oct 202411:51 amRNSHolding(s) in Company
2nd Oct 20245:35 pmRNSGrant of Options under 2024 SAYE Scheme
11th Sep 20247:00 amRNSDirectorate Change
5th Sep 202411:49 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.